Senior insider sale
Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$7.48M
93.61K shares
What this filing means
SMITH HUNTER C plans to sell 93.61K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $7.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2025ACC: 0001950047-25-005682
Officer· Chief Financial Officer
Since Mar 2026
93.61K
Shares to sell
$7.48M
Approx. market value
28.09K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/12/2025
28.09KTotal acquired28.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2025 | Exercise of Stock Options Cash | 28.09K | — |
| Total | 28.09K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
42.12K
Market value
$3.39M
7/9/2025
—Completed
Units to sell
23.40K
Market value
$1.44M
5/30/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
28.09K
Market value
$2.65M
8/12/2025
Total
Units
93.61K
Value
$7.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/9/2025 | 42.12K | $3.39M | — | Completed |
5/30/2025 | 23.40K | $1.44M | — | Completed |
| Planned — Approximate Date | ||||
8/12/2025 | 28.09K | $2.65M | NASDAQ | Planned |
| Total | 93.61K | $7.48M | ||